Recent News

• 04.26.2025 - Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
• 04.26.2025 - Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
• 04.26.2025 - Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
• 04.25.2025 - Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results
• 04.24.2025 - Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
• 04.18.2025 - New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved
• 03.30.2025 - Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
• 03.09.2025 - SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
• 03.06.2025 - Medtronic announces cash dividend for fourth quarter of fiscal year 2025
• 02.24.2025 - Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

Recent Filings

• 04.23.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.26.2025 - 3 Initial statement of beneficial ownership of securities
• 03.17.2025 - 8-K Current report
• 03.10.2025 - 4/A Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 3 Initial statement of beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.18.2025 - 8-K Current report